SCHEMBL797245

SCHEMBL797245

COCCOCCOCCOc1cc(C(=O)OC)cc(OCCOCCOCCOC)c1OCCOCCOCCOC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
TNFRSF1A P19438 1/20 0.46
MAPT P10636 3/20 0.44
TSHR P16473 2/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
KDM4E B2RXH2 3/20 0.40
LMNA P02545 3/20 0.40
HPGD P15428 2/20 0.40
ALDH1A1 P00352 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
RAB9A P51151 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26545256 1.00 KMT2A (0.48) KMT2AMEN1TNFRSF1AMAPTTSHR
SCHEMBL23533857 1.00 KMT2A (0.48) KMT2AMEN1TNFRSF1AMAPTTSHR
SCHEMBL2533850 1.00 KMT2A (0.48) KMT2AMEN1TNFRSF1AMAPTTSHR
SCHEMBL14664421 0.95 KMT2A (0.51) KMT2AMEN1TNFRSF1AMAPTTSHR
SCHEMBL18281580 0.87 MEN1 (0.48) KMT2AMEN1TNFRSF1ATSHRCA12
SCHEMBL17971074 0.86 KMT2A (0.38) KMT2AMEN1TNFRSF1AMAPTTSHR
SCHEMBL13035923 0.86 LMNA (0.51) KMT2AMEN1TNFRSF1AMAPTL3MBTL1
SCHEMBL16333870 0.86 TNFRSF1A (0.47) KMT2AMEN1TNFRSF1AMAPTTSHR
SCHEMBL13498580 0.86 TNFRSF1A (0.47) KMT2AMEN1TNFRSF1ATSHRCA12
SCHEMBL26545271 0.86 TNFRSF1A (0.47) KMT2AMEN1TNFRSF1ATSHRCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12540278-B2 Temperature programmable small molecules for thermoresponsive smart windows and applications thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2026-02-03 US disclosed
US-20240400898-A1 TEMPERATURE PROGRAMMABLE SMALL MOLECULES FOR THERMORESPONSIVE SMART WINDOWS AND APPLICATIONS THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2024-12-05 US disclosed
EP-4412598-A1 TEMPERATURE PROGRAMMABLE SMALL MOLECULES FOR THERMORESPONSIVE SMART WINDOWS AND APPLICATIONS THEREOF Council Of Scientific & Industrial Research (IN) 2024-08-14 EP disclosed
EP-4347550-A1 ONE-COMPONENT DELIVERY SYSTEM FOR NUCLEIC ACIDS The Trustees of the University of Pennsylvania (US) 2024-04-10 EP disclosed
WO-2023058048-A1 TEMPERATURE PROGRAMMABLE SMALL MOLECULES FOR THERMORESPONSIVE SMART WINDOWS AND APPLICATIONS THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2023-04-13 WO disclosed
WO-2022251191-A1 ONE-COMPONENT DELIVERY SYSTEM FOR NUCLEIC ACIDS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2022-12-01 WO disclosed
WO-2018125524-A1 DENDRITIC LIGANDS FOR CONTROLLING SELF ASSEMBLY AND SURFACE POLARITY OF NANOPARTICLES, AND HYBRID NANOPARTICLES PRODUCED THEREFROM THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2018-07-05 WO disclosed
US-9079999-B2 Methods for preparing polymer coatings by electrochemical grafting of polymer brushes, compositions prepared thereby and compositions for preparing the coatings ADVINCULA RIGOBERTO (US) 2015-07-14 US disclosed
US-20150133653-A1 COMPOUNDS AND BIOLOGICAL MATERIALS AND USES THEREOF PHOTOBIOTICS LIMITED (GB) 2015-05-14 US disclosed
US-20150133653-A1 COMPOUNDS AND BIOLOGICAL MATERIALS AND USES THEREOF PHOTOBIOTICS LIMITED (GB) 2015-05-14 US disclosed
US-8404216-B2 Dendritic chelated compounds, methods for making the same and pharmaceutical compositions containing the same CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-03-26 US disclosed
US-8404216-B2 Dendritic chelated compounds, methods for making the same and pharmaceutical compositions containing the same CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-03-26 US disclosed
US-20120070377-A1 COMPOUNDS AND BIOLOGICAL MATERIALS AND USES THEREOF PHOTOBIOTICS LIMITED (GB) 2012-03-22 US disclosed
US-20120070377-A1 COMPOUNDS AND BIOLOGICAL MATERIALS AND USES THEREOF PHOTOBIOTICS LIMITED (GB) 2012-03-22 US disclosed
US-20100104512-A1 Dendritic Chelated Compounds, Methods for Making the Same and Pharmaceutical Compositions Containing the Same CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2010-04-29 US disclosed
US-20100104512-A1 Dendritic Chelated Compounds, Methods for Making the Same and Pharmaceutical Compositions Containing the Same CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2010-04-29 US disclosed
US-20090236229-A1 METHODS FOR PREPARING POLYMER COATINGS BY ELECTROCHEMICAL GRAFTING OF POLYMER BRUSHES, COMPOSITIONS PREPARED THEREBY AND COMPOSITIONS FOR PREPARING THE COATINGS THE UNIVERSITY OF HOUSTON SYSTEM (US) 2009-09-24 US disclosed
WO-2008043911-A2 DENDRITIC CHELATED COMPOUNDS, METHODS FOR MAKING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2008-04-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150133653-A1 COMPOUNDS AND BIOLOGICAL MATERIALS AND USES THEREOF SSB, HLA-B, BDKRB1 KMT2A 3721/4885MEN1 516/4885TNFRSF1A 397/4885
US-12540278-B2 Temperature programmable small molecules for thermoresponsive smart windows and applications thereof CRY1, C1S, CRY2 KMT2A 715/4885MEN1 2168/4885TNFRSF1A 369/4885
US-20120070377-A1 COMPOUNDS AND BIOLOGICAL MATERIALS AND USES THEREOF SSB, HLA-B, BDKRB1 KMT2A 3497/4885MEN1 507/4885TNFRSF1A 513/4885
US-20100104512-A1 Dendritic Chelated Compounds, Methods for Making the Same and Pharmaceutical Compositions Containing the Same ZYX, CXCR4, ZFX KMT2A 3370/4885MEN1 398/4885TNFRSF1A 2213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.